MEDP

MEDP

USD

Medpace Holdings Inc. Common Stock

$301.565-0.055 (-0.018%)

السعر في الوقت الحقيقي

Healthcare
Diagnostics & Research
الولايات المتحدة

مخطط الأسعار

Loading Chart...

المقاييس الرئيسية

مقاييس السوق
أساسيات الشركة
إحصاءات التداول

مقاييس السوق

الافتتاح

$301.620

الأعلى

$301.910

الأدنى

$301.170

الحجم

0.31M

أساسيات الشركة

القيمة السوقية

8.7B

الصناعة

Diagnostics & Research

البلد

United States

إحصاءات التداول

متوسط الحجم

0.49M

البورصة

NMS

العملة

USD

نطاق 52 أسبوعاً

الأدنى $250.05الحالي $301.565الأعلى $459.77

أخبار ذات صلة

Analyst Upgrades

Truist Securities Maintains Hold on Medpace Hldgs, Lowers Price Target to $300

Truist Securities analyst Jailendra Singh maintains Medpace Hldgs with a Hold and lowers the price target from $333 to $300.

عرض المزيد
Truist Securities Maintains Hold on Medpace Hldgs, Lowers Price Target to $300
Analyst Upgrades

Baird Maintains Neutral on Medpace Hldgs, Lowers Price Target to $313

Baird analyst Eric Coldwell maintains Medpace Hldgs with a Neutral and lowers the price target from $340 to $313.

عرض المزيد
Baird Maintains Neutral on Medpace Hldgs, Lowers Price Target to $313
Analyst Upgrades

William Blair Downgrades Medpace Hldgs to Market Perform

William Blair analyst Max Smock downgrades Medpace Hldgs from Outperform to Market Perform.

عرض المزيد
William Blair Downgrades Medpace Hldgs to Market Perform
BusinessWire

Medpace Holdings, Inc. Reports First Quarter 2025 Results

Revenue of $558.6 million in the first quarter of 2025 increased 9.3% from revenue of $511.0 million for the comparable prior-year period, representing a backlog conversion rate of 19.2%. Net new business awards were

عرض المزيد
Medpace Holdings, Inc. Reports First Quarter 2025 Results
Analyst Upgrades

TD Cowen Downgrades Medpace Hldgs to Hold, Lowers Price Target to $328

TD Cowen analyst Charles Rhyee downgrades Medpace Hldgs from Buy to Hold and lowers the price target from $370 to $328.

عرض المزيد
TD Cowen Downgrades Medpace Hldgs to Hold, Lowers Price Target to $328
Analyst Upgrades

Truist Securities Maintains Hold on Medpace Hldgs, Lowers Price Target to $333

Truist Securities analyst Jailendra Singh maintains Medpace Hldgs with a Hold and lowers the price target from $347 to $333.

Analyst Upgrades

Mizuho Maintains Outperform on Medpace Hldgs, Lowers Price Target to $355

Mizuho analyst Ann Hynes maintains Medpace Hldgs with a Outperform and lowers the price target from $400 to $355.

ابق على اطلاع

تعيين تنبيهات الأسعار، الحصول على تحديثات تحليل الذكاء الاصطناعي وأخبار السوق في الوقت الحقيقي.